ACR Convergence 2026

November 6-11, 2026. Orlando, Florida.

View by Number View by Title View Sessions

All • a b c d e [f] g h i j k l m n o p q r s t u v w x y z

Abstract Number: 0680

Factors Associated with Duration of Time to Diagnosis in Adults with Chronic Nonbacterial Osteomyelitis Enrolled in The SAPHO-CNO Study
Abstract Number: 0596

Factors Associated with Favorable Oral Health Care Practices in People with Autoimmune and Inflammatory Rheumatic Diseases
Abstract Number: 2624

Factors associated with initiation of conventional and biological/targeted synthetic DMARDs in SAPHO síndrome. Results from SAPHO-SPAIN registry
Abstract Number: 0950

Factors Associated with Longitudinal Skin Severity in Early Systemic Sclerosis: Findings from the Prospective CONQUER Cohort
Abstract Number: 0423

Factors associated with mortality in patients with Sjögren disease: analysis of the ASSESS cohort
Abstract Number: 1925

Factors Associated with Resolution of Walking Difficulty One Year After Total Knee Arthroplasty for Knee Osteoarthritis
Abstract Number: 0597

Factors Associated with Self-Efficacy and Health Outcomes in Rheumatic and Musculoskeletal Diseases
Abstract Number: 0598

Factors Associated with Sexual Inactivity in Patients with Rheumatic Disease-Associated Interstitial Lung Disease
Abstract Number: 1877

Factors Associated with Successful Transition from Pediatric to Adult Rheumatology Care
Abstract Number: 1508

Factors Associated With Sustained Remission After bDMARD Withdrawal In Juvenile Idiopathic Arthritis: A Multicenter Study
Abstract Number: 1533

Factors Influencing Receipt of Vaccinations Among Patients with Vasculitis
Abstract Number: 0624

Falling Through the Cracks: Adherence to Guideline-Based Osteoporosis Screening and Treatment in Rheumatoid Arthritis Patients on Chronic Glucocorticoids in an Academic Rheumatology Clinic
Abstract Number: 2750

Falls in a Pooled U.S. Cohort of Adults with Systemic Lupus Erythematosus
Abstract Number: 0534

Family Planning and Perceived Medication Risks in Systemic Lupus Erythematosus Pregnancies
Abstract Number: 2720

Fast Track Giant Cell Arteritis Pathway in the UK: A Real World Evaluation and Pre-Post Analysis of Access and Diagnostic Yield
Abstract Number: 0637

Faster vs. Slower Medial Fixed JSW Loss Trajectories: Predictors of These Trajectories and Their Association with the Risk of Knee Replacement
Abstract Number: 1470

Fatherhood intentions among patients living with immune-mediated rheumatic musculoskeletal diseases (IM-RMDs): a scoping review
Abstract Number: 2035

FBXW11 inhibition reprograms activated rheumatoid arthritis (RA) fibroblast-like synoviocytes (FLS) to a non-inflammatory phenotype and suppresses inflammatory arthritis
Abstract Number: 2466

Fear of Movement as a Behavioral Pathway Linking Pain-Related Factors and Physical Function in Early Rheumatoid Arthritis: A Cross-Sectional Mediation Analysis
Abstract Number: 0787

Feasibility and Acceptability of PREVAIL: A model of care to systematically integrate exercise guidance and physical therapy in routine rheumatology care
Abstract Number: 1133

Feasibility and Limitations of Federated EHR Data for VEXAS Syndrome Ascertainment and Treatment Research
Abstract Number: 1914

Feasibility of a Telehealth Physical and Mental Health Intervention for Black Adults with Knee Osteoarthritis and Psychological Symptoms
Abstract Number: 2362

Feasibility of automated identification of Sjögren’s disease patients from clinical notes for research purposes: application to an 11-million-patient clinical data warehouse
Abstract Number: 1966

Fecal Metabolomic Signatures in Systemic Sclerosis-Associated Interstitial Lung Disease
Abstract Number: 2898

Feedback on Feedback: Impact of Iterative AI Assisted Feedback on the Quality of Written Narrative Evaluations
Abstract Number: 0171

Female hormonal exposures and the risk of incident giant cell arteritis and polymyalgia rheumatica: results from the French E3N prospective cohort study.
Abstract Number: 0097

Fibrin deposits and SPP1hi macrophages mark active tissue remodeling niches from early to established RA
Abstract Number: 2063

Fibrinogen Modified with Citrulline and Malondialdehyde-Acetaldehyde Activates p38 and NFᴋB Signaling in Macrophages to Promote Fibrotic Responses in Coronary Endothelium
Abstract Number: 1080

Fibroblast PIEZO1 Promotes Autoimmune Valvular Carditis
Abstract Number: 0982

Fibroblast TWEAK Receptor Drives Multi-organ Fibrosis in Systemic Sclerosis
Abstract Number: 2809

Fibroblast-NK-myeloid cell axis in the pathogenesis of juvenile idiopathic arthritis
Abstract Number: 1553

Fibromyalgia is worsened by metabolic syndrome and imidazole agonist antihypertensive drug moxonidine use is associated with improved outcomes.
Abstract Number: 0710

FibroScan-Confirmed Hepatic Steatosis and FIB-4 Risk Burden in Gout: A Nationally Representative Two-Stage Analysis
Abstract Number: 2780

Fibrosing pattern and Gannon score predict one-year mortality in critically ill patients with interstitial lung disease (ILD): a multicenter study
Abstract Number: 2135

Ficolin-2 as a biomarker of disease activity and prognosis in microscopic polyangiitis and granulomatosis with polyangiitis
Abstract Number: 2721

Financial Toxicity Is Associated With RA-Related Hospitalization: A NinJa Registry Cohort Study
Abstract Number: 0129

Findings from Three Years of the ClinGen Monogenic Systemic and Incomplete Lupus Gene Curation Expert Panel
Abstract Number: 2070

Fine-mapping of the HLA region identifies independent susceptibility alleles in psoriatic arthritis
Abstract Number: 2203

First Clinical Proof of Concept of Intravenous RXIM002, a Targeted Lipid Nanoparticle Circular RNA Therapy, for In Vivo Anti-CD19 Chimeric Antigen Receptor T-Cell Generation in Refractory Systemic Lupus Erythematosus
Abstract Number: 2171

First non-Raynaud’s phenomenon sign/symptom predicts MACE occurrence in systemic sclerosis: a monocentric long-term analysis
Abstract Number: 2856

First-in-class Oral IRF5 Degrader, KT-579, Demonstrates Significant Activity Alone or in the Presence of Background Therapies in Preclinical Lupus Models
Abstract Number: 2400

First-In-Human Application of [177Lu]Lu-FAPi as a Theranostic Agent in Difficult-To-Treat Inflammatory Arthritis
Abstract Number: 0519

First-in-Human Non-Viral Bispecific BCMA/CD19 CAR-T in Refractory SLE, SSc, and SS: Safety, Dual Pharmacodynamics, and Immune Reset
Abstract Number: 2204

First-in-Human Safety, Tolerability, Pharmacokinetics, and Immunogenicity of NTR-1011, a Recombinant DNASE1L3-Albumin Fusion Protein for Subcutaneous Delivery: Results from a Phase 1 Single Ascending Dose Study in Healthy Volunteers
Abstract Number: 1408

First[JR1.1]-in-Human Single and Multiple Ascending Dose Study of FT2109, a Selective Oral TNFR1 Signaling Inhibitor, in Healthy Participants
Abstract Number: 2523

Five-Year Cardiovascular and Clinical Outcomes in Relapsing Polychondritis Without Documented Structural Damage Compared With Seropositive Rheumatoid Arthritis
Abstract Number: 2625

Five-Year Follow-Up of Anakinra Treatment in Familial Mediterranean Fever: A Retrospective Single-Center Study
Abstract Number: 1827

Five-Year Outcomes from the Start Time Optimization of Biologics in Polyarticular-Juvenile Idiopathic Arthritis Study
Abstract Number: 2576

Flare Burden in the First 12 Weeks Predicts Long-Term Functional Limitations and Pain Intensity in People with Low Back Pain
Abstract Number: 0450

Flare Risk After Tapering or Withdrawal of Conventional Synthetic DMARDs in Adults with Rheumatoid Arthritis in Sustained Remission or Low Disease Activity: A Systematic Review and Living Meta-Analysis
Abstract Number: 2205

Flare-Free Survival After Hydroxychloroquine Tapering in Systemic Lupus Erythematosus: A Real-World Retrospective Cohort Study
Abstract Number: 0788

Flexibility and Acknowledgement of Patient Needs Are Key Facilitators of Clinician Use of a Shared Decision-Making Tool for Rheumatoid Arthritis Treatment
Abstract Number: 1486

Flipped Classroom Question Writing vs AI-Generated Multiple Choice Questions: A Comparison of Question Quality and Educational Value for Rheumatology Fellows
Abstract Number: 2078

Flow Cytometric Profiling of Synovial Fluid Extracellular Vesicles Identifies Distinct Immune Signatures in Inflammatory Arthritis
Abstract Number: 0767

Follow the Yellow Brick Road: Family Perspectives on Barriers and Facilitators to Timely Pediatric Rheumatic Diagnosis in an Urban Health System
Abstract Number: 0911

Food Insecurity And Perceived Stress In Menopausal Women With Rheumatoid Arthritis
Abstract Number: 2172

Forced Vital Capacity Trajectories During the Treatment-Naïve Period in Systemic Sclerosis: A 20-Year Ambispective Cohort Study
Abstract Number: 0312

Forecasting Pediatric Lupus: A Latent Class Analysis-Based Model Integrating 2019 EULAR/ACR Criteria and Therapeutic Regimens to Identify Subclasses Within Clinically Heterogeneous Disease
Abstract Number: 1176

FORMULATION MATTERS! Problems in Drug Physicochemical Properties and Plasma Concentration Variability May Obscure Drug Effects – Impact on the RECONNOITER-1 Trial of AISA-021 on Systemic Sclerosis Associated Raynaud’s
Abstract Number: 1031

Four-week Changes in Collagen Degradation Biomarkers are Prognostic of 24-week Clinical Response in Psoriatic Arthritis: A Biomarker-Guided Stratification Approach
Abstract Number: 0789

Fourteen-Year Outcomes of an Integrated Rheumatology-Primary Care Musculoskeletal Unit: Effects on Access to Care and Referral Patterns
Abstract Number: 0451

Fracture Outcomes Associated with GLP-1 Receptor Agonists in Rheumatoid Arthritis Patients with Osteoporosis Stratified by Diabetes Status
Abstract Number: 0625

Fracture Rates In 6475 Individuals with Osteogenesis lmperfecta by Age and Clinical Severity
Abstract Number: 1746

Frailty and 30-Day Readmissions in Rheumatoid Arthritis: A Nationwide Readmissions Database Study, 2016-2021
Abstract Number: 0813

Frailty and All-Cause Mortality in Older Adults with and without Rheumatoid Arthritis: A Study of Medicare Beneficiaries
Abstract Number: 2928

Frailty and Incident Geriatric Syndromes in Community-Dwelling Older Adults with Arthritis: 13-Year Longitudinal Evidence from the NHATS
Abstract Number: 2429

Frailty and Serious Infection Risk in Veterans with Rheumatoid Arthritis
Abstract Number: 0452

Frailty and Treatment Safety in Elderly-Onset Rheumatoid Arthritis: Usefulness of the FRAIL Scale
Abstract Number: 1155

Frailty Frequency In Patients With ANCA-Associated Vasculitis And Its Relationship With Glucocorticoid Exposure And Body Composition
Abstract Number: 2250

Frailty is associated with Brain Atrophy in Systemic Lupus Erythematosus
Abstract Number: 1442

Frailty Risk in Incident Rheumatoid Arthritis Compared with Matched Non-RA Individuals, 2000-2019: Temporal Trends and Pre-Index Mobility Signal
Abstract Number: 0520

Framework for Harmonizing Clinical Instrument Measures Across Immune-Mediated Conditions
Abstract Number: 1342

Frequency and Predictors of Drug Free Remission in Psoriatic Arthritis: Insights from a Longitudinal Cohort
Abstract Number: 1443

Frequency and risk factors for the progression of rheumatoid arthritis-related interstitial lung disease: a cohort study
Abstract Number: 2661

From Assessment to Action: Physician Global Assessment and Treatment Escalation in Inflammatory Arthritis
Abstract Number: 1837

From At-Risk Arthralgia to Rheumatoid Arthritis: Validation of the EULAR/ACR Risk Stratification Score in a Large Real-World Cohort Reuma-Check
Abstract Number: 1989

From autoreactive to malignant B cells: molecular profiling at the intersection of systemic lupus erythematosus and B-cell lymphoma
Abstract Number: 1851

From Genetic Risk to Therapeutic Target: The Myeloid CARD9 Regulatory Axis in Axial Spondyloarthritis
Abstract Number: 2921

From Hematologic Malignancies to Rheumatic Disease: Expanding the Role of Intravenous Immunoglobulin in Secondary Immunodeficiency
Abstract Number: 1859

From Histology to Phenotype: Multicenter study defining salivary gland pathotypes to guide patient stratification in Sjögren’s Disease
Abstract Number: 0790

From Pilot to Practice: Real-World Uptake of HCQ-SAFE, a Lupus Shared Decision-Making Tool, Mapped to RE-AIM via 18 Months of Google Analytics Data
Abstract Number: 0453

FT839: An Off-the-Shelf, Dual CAR T-Cell Therapy for the Comprehensive Elimination of Multicellular Drivers of Rheumatoid Arthritis
Abstract Number: 2941

FTB-918: A Dual Targeting Antibody With TRBV9+ T Cell Depletion and IL-17A Neutralization for the Treatment of Axial Spondyloarthritis
Abstract Number: 2964

Functional Limitations as Barriers to Increasing Steps/day in Adults with Knee Osteoarthritis

All • a b c d e [f] g h i j k l m n o p q r s t u v w x y z